Salarius Pharmaceuticals Presents SP-3164 Preclinical Data
Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s lymphomas, and significantly better...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-27, 20:39
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-27, 20:10
Amarin to Present at SVB Securities Global Biopharma
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail,...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-27, 15:08
PARADIGM DRILLERS ARRIVE AT BRUSSELS CREEK FOR DRILL
Vancouver, BC, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Recharge Resources Ltd. (“Recharge”) (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) announced that Paradigm...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-01-27, 11:11
GobiMin Inc. to hold Special Meeting of Shareholders for
Toronto, Canada, Jan. 26, 2023 (GLOBE NEWSWIRE) -- (TSXV:GMN) GobiMin Inc. (“GobiMin” or the “Company”) today announces that it has mailed to registered...
